Is Strata Critical Medical, Inc. (SRTA) Overvalued?
We dive into why Strata Critical Medical, Inc. (SRTA) could be considered overvalued on 2026-08-14, based on AAII’s Value Score and Grade.Jenna Brashear
Stock Evaluator: Strata Critical Medical, Inc. (SRTA)
Strata Critical Medical, Inc. SRTA
$5.33
0.06
1.14%
September 25, 2026 4:00:00 PM
EST
Volume: 519,605
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
Commentary & Analysis
Why Strata Critical Medical, Inc.’s (SRTA) Stock Is Up 5.46%
As of Friday, August 07, Strata Critical Medical, Inc.’s SRTA share price has surged by 5.46%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Strata Critical Medical, Inc.’s (SRTA) Stock Is Up 5.31%
As of Monday, August 03, Strata Critical Medical, Inc.’s SRTA share price has surged by 5.31%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Strata Critical Medical, Inc.’s (SRTA) Stock Is Up 7.46%
As of Monday, June 15, Strata Critical Medical, Inc.’s SRTA share price has surged by 7.46%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Strata Critical Medical, Inc.’s (SRTA) Stock Is Down 5.96%
As of Tuesday, June 09, Strata Critical Medical, Inc.’s SRTA share price has dipped by 5.96%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Financial Summary
| Share Statistics | SRTA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $471.5 | $1,744.7 | 37% |
|
| Shares Out (Mil) | 86.2 | 77.7 | 59% |
|
| Institutional Ownership | 77.5% | 87.7% | 47% |
|
| Float (Mil) | 58.2 | 55.7 | 50% |
|
| Beta | 2.26 | 0.81 | 94% |
|
| Avg Daily Volume (000s) | 696 | 727 | 61% |
|
| Price Change (52-week) |
2.7% | 77.9% | 53% |
|
| Growth | SRTA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 31.3% | 10.6% | 90% |
|
| Net Income (5yr) | 24.8% | (0.3%) | 80% |
|
| EPS (5yr) | 20.5% | 3.0% | 69 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 26.8% | (17.3%) | 84% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | ($0.020) | na | ($0.093) | |
| Month Ago EPS | na | na | na | |
| # Rev Up | 1 | na | 1 | |
| # Rev Down | 0 | na | 0 | |
| Three Months Ago EPS | ($0.040) | na | ($0.140) | |
| Year/Year Chg | (83.6%) | na | na | |
| Financials | SRTA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $256 | $1,505 | 34% |
|
| Net Income (TTM) (Mil) | $40 | $26 | 53% |
|
| EPS (TTM) | $0.475 | $0.200 | 53% |
|
| Operating Cash Flow (TTM) (Mil) | ($36) | $157 | 11% |
|
| Net Cash Flow (TTM) (Mil) | ($44) | $2 | 21% |
|
| Long-Term Debt (Q1) (Mil) | $3 | $374 | 22% |
|
| Enterprise Value (Q1) (Mil) | $454 | $2,284 | 33% |
|
| Valuation | SRTA | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.69 | 2.89 | 45% |
|
| P/E | na | 25.1 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | SRTA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 21.3% | 27.6% | 23% |
|
| Net Margin | 15.7% | 1.2% | 73% |
|
| ROA | 13.6% | 2.1% | 92% |
|
| ROE | 16.0% | 7.2% | 73% |
|
| Liabilities to Assets | 16.0% | 61.3% | 10% |
|
| F-Score | 5 | 5 | 50% |
|
Strata Critical Medical, Inc. did not pass any screens on 9/25/2026.
